ABC (Atrial fibrillation Better Care) Pathway and Healthcare Costs in Atrial Fibrillation: The ATHERO-AF Study
Patients with atrial fibrillation are often elderly and have multiple comorbidities, leading to a high risk of cardiovascular events1,2,3 despite the use of oral anticoagulants, whether with vitamin K antagonists (VKAs) or non-vitamin K antagonist oral anticoagulants (NOACs).
Source: The American Journal of Medicine - Category: General Medicine Authors: Daniele Pastori, Alessio Farcomeni, Pasquale Pignatelli, Francesco Violi, Gregory YH Lip Tags: Clinical Research Study Source Type: research
More News: Atrial Fibrillation | Cardiology | Cardiovascular | General Medicine | Healthcare Costs | Heart | Study | Vitamin K | Vitamins